- Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.
- The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.
- The unit generated $120M in sales last year. (PR)
From other sites
at CNBC.com (Jan 5, 2015)
at CNBC.com (Nov 19, 2014)
at CNBC.com (Nov 14, 2014)
at CNBC.com (Nov 5, 2014)
at CNBC.com (Nov 3, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs